---
id        : TGFb.E-GEOD-10311.1
accession : E-GEOD-10311
platform  : A-AFFY-44
pathway   : TGFb
cells     : human osteoblasts
treatment : BMP-2
effect    : activating
hours     : 24

control   :
    - GSE10311GSM260302
    - GSE10311GSM260303
    - GSE10311GSM260304
    - GSE10311GSM260305
    - GSE10311GSM260306
    - GSE10311GSM260307
perturbed :
    - GSE10311GSM260314
    - GSE10311GSM260321
    - GSE10311GSM260322

---
id        : TGFb.E-GEOD-10311.2
accession : E-GEOD-10311
platform  : A-AFFY-44
pathway   : TGFb
cells     : human osteoblasts
treatment : dexamethasone
effect    : inhibiting
hours     : 24

control   :
    - GSE10311GSM260302
    - GSE10311GSM260303
    - GSE10311GSM260304
    - GSE10311GSM260305
    - GSE10311GSM260306
    - GSE10311GSM260307
perturbed :
    - GSE10311GSM260323
    - GSE10311GSM260324
    - GSE10311GSM260325

---
id        : TGFb.E-GEOD-10311.3
accession : E-GEOD-10311
platform  : A-AFFY-44
pathway   : TGFb
cells     : human osteoblasts
treatment : BMP-2
effect    : activating
hours     : 2

control   :
    - GSE10311GSM260311
    - GSE10311GSM260312
    - GSE10311GSM260313
perturbed :
    - GSE10311GSM260308
    - GSE10311GSM260309
    - GSE10311GSM260310

---
id        : TGFb.E-GEOD-10311.4
accession : E-GEOD-10311
platform  : A-AFFY-44
pathway   : TGFb
cells     : human osteoblasts
treatment : dexamethasone
effect    : inhibiting
hours     : 2

control   :
    - GSE10311GSM260311
    - GSE10311GSM260312
    - GSE10311GSM260313
perturbed :
    - GSE10311GSM260326
    - GSE10311GSM260327
    - GSE10311GSM260328
...
